Morningstar Investment Services’s Takeda Pharmaceutical TAK Stock Holding History

Morningstar Investment Services’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-55,840	Closed	-$761K	–	252
2021 Q4	$761K	Buy	55,840 +2,529	+5%	+$35.5K	0.01%	183
2021 Q3	$873K	Buy	53,311 +1,049	+2%	+$17.6K	0.01%	174
2021 Q2	$880K	Buy	52,262 +2,029	+4%	+$34.5K	0.01%	174
2021 Q1	$922K	Sell	50,233 -2,923	-5%	-$52.6K	0.01%	168
2020 Q4	$967K	Sell	53,156 -5,247	-9%	-$92.1K	0.01%	168
2020 Q3	$1.07M	Sell	58,403 -3,679	-6%	-$67K	0.02%	163
2020 Q2	$1.12M	Sell	62,082 -4,493	-7%	-$80.7K	0.02%	159
2020 Q1	$1.04M	Sell	66,575 -32,715	-33%	-$593K	0.02%	161
2019 Q4	$1.96M	Sell	99,290 -5,208	-5%	-$99.6K	0.03%	134
2019 Q3	$1.8M	Sell	104,498 -6,410	-6%	-$111K	0.03%	128
2019 Q2	$1.96M	Sell	110,908 -8,185	-7%	-$149K	0.03%	147
2019 Q1	$2.43M	Buy	+119,093	New	+$2.4M	0.04%	143

Other funds holding TAK

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morningstar Investment Services's TAK Position: Q1 2022 in Review

Morningstar Investment Services sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 55,840 shares — an estimated $761K sold.

Morningstar Investment Services first reported a position in TAK in Q1 2019 and held it in 12 quarters. The position peaked at $2.43M in Q1 2019. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Morningstar Investment Services reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Morningstar Investment Services sold 55,840 Takeda Pharmaceutical shares in Q1 2022, an estimated $761K.
Morningstar Investment Services first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 12 quarters.
Morningstar Investment Services's Takeda Pharmaceutical position peaked at $2.43M in Q1 2019.
288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Morningstar Investment Services's 13F filing for Q1 2022, filed 10 May 2022.